{"public_id":"cl_9da066814d142a76df48506858fa3b37","status":"active","superseded_by_public_id":null,"corpus_id":49433924,"text":"The optimized molecule is predicted to bind more strongly to DapE than its natural substrate, making it a promising inhibitor.","confidence":0.93,"paper":{"corpus_id":49433924,"title":"L-Captopril and its derivatives as potential inhibitors of microbial enzyme DapE: A combined approach of drug repurposing and similarity screening.","url":"https://sah.borca.ai/papers/49433924"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.93,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_0d81d9df0bfd5a7fa34ff918e81a7343","name":"DapE enzyme","description":"A microbial enzyme studied as an antibiotic target.","types":["enzyme","antibiotic target"],"url":"https://sah.borca.ai/concepts/co_0d81d9df0bfd5a7fa34ff918e81a7343"},{"public_id":"co_9fff849a6cf11f29a70387f464e4e72d","name":"natural substrate","description":"The endogenous substrate of DapE used as a binding-affinity comparison reference.","types":["substrate"],"url":"https://sah.borca.ai/concepts/co_9fff849a6cf11f29a70387f464e4e72d"},{"public_id":"co_f918d909a7e0c79b418add594094f1ad","name":"L-Captopril-based inhibitors","description":"Modeled derivative molecules designed by modifying the L-Captopril scaffold.","types":["compound class","inhibitor"],"url":"https://sah.borca.ai/concepts/co_f918d909a7e0c79b418add594094f1ad"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_9da066814d142a76df48506858fa3b37"}